Endo International | ENDP - DETTE



DETTE Changement Date
AbbVie USD 67.5B 67.5B 2025-12
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 42.5B 3.6M 2025-12
Heron Therapeutics USD 149.65M 157K 2024-09
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Ligand Pharmaceuticals USD 451.49M 494K 2025-12
Merck USD 49.34B 7.97B 2025-12
Novartis USD 47B 11.62B 2026-03
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.64B 4.5M 2025-12
Pfizer USD 63.73B 231M 2026-03
Phibro Animal Health USD 474.17M 730K 2024-09
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
Takeda JPY 4.85T 208B 2025-12
Teva Pharmaceutical Industries USD 17.09B 21M 2025-12
Xeris Pharmaceuticals USD 258.55M 899K 2026-03
Zoetis USD 9.24B 1.96B 2025-12